Evidence map›Paper›PMID 21106760›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Nicotinamide adenine dinucleotide (NAD)-regulated DNA methylation alters CCCTC-binding factor (CTCF)/cohesin binding and transcription at the BDNF locus.

Jufang Chang, Bin Zhang, Helen Heath, Niels Galjart, Xinyu Wang, Jeffrey Milbrandt

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. NADFrontiers in neurology · 2026
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Prognostic value of nicotinamide adenine dinucleotide (NADJournal of gastrointestinal oncology · 2022
    Article
  9. Review
  10. Article
  11. Review
  12. Cohesin Mutations in Cancer: Emerging Therapeutic Targets.International journal of molecular sciences · 2021
    Review
  13. Article
  14. CTCF Mediates Replicative Senescence Through POLD1.Frontiers in cell and developmental biology · 2021
    Article
  15. Article
  16. NADSignal transduction and targeted therapy · 2020
    Review
  17. Article
  18. Article
  19. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jufang ChangDepartment of Genetics, and Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO 63110, USA.
Bin Zhang
Helen Heath
Niels Galjart
Xinyu Wang
Jeffrey Milbrandt
Erasmus MC · NLErasmus University Rotterdam · NLHope Center for Neurological Disorders · US

Funding

PHYSIOLOGY AND GENETICS OF THE GDNF HOMOLOG NEURTURINR01AG013730 · NIA · WASHINGTON UNIVERSITY · PI JEFFREY D MILBRANDT · 1996 to 2026
$10.6M
Washington University Center for Translational NeuroscienceP30NS057105 · NINDS · WASHINGTON UNIVERSITY · PI HOLTZMAN, DAVID M. · 2006 to 2011
$8.7M
Regulating NAD Metabolism to Inhibit Axon Degeneration in Neurodegenerative DiseasesRF1AG013730 · NIA · WASHINGTON UNIVERSITY · PI MILBRANDT, JEFFREY D · 2017 to 2017
$2.8M
Loss of Nkx3.1-an Initiating Event in Prostate CancerR01CA111966 · NCI · WASHINGTON UNIVERSITY · PI MILBRANDT, JEFFREY D · 2005 to 2009
$1.4M
Compromised LDH activity causes motor deficits and hastens ALS progressionR56AG013730 · NIA · WASHINGTON UNIVERSITY · PI MILBRANDT, JEFFREY D · 2022 to 2022
$503k
NCI NIH HHS CA111966NCI NIH HHS R01 CA111966NIA NIH HHS AG013730NIA NIH HHS R01 AG013730NIA NIH HHS R56 AG013730NIA NIH HHS RF1 AG013730NINDS NIH HHS P30 NS057105
6 · The paper itself

Abstract

Cellular metabolism alters patterns of gene expression through a variety of mechanisms, including alterations in histone modifications and transcription factor activity. Nicotinamide adenine dinucleotide (NAD)-dependent proteins such as poly(ADP ribose) polymerases (PARPs) and sirtuin deacetylases play important roles in this regulation, thus NAD provides a crucial link between metabolism and these cellular signaling processes. Here, we found that lowering NAD levels in mouse primary cortical neurons led to decreased activity-dependent BDNF expression. The altered BDNF transcription occurred independently of Sirt or Parp activities; instead, low NAD levels promoted increased DNA methylation of the activity-dependent BDNF promoter. Increased methylation at this promoter triggered the dissociation of the insulator protein CTCF as well as the accompanying cohesin from the BDNF locus. The loss of these proteins resulted in histone acetylation and methylation changes at this locus consistent with chromatin compaction and gene silencing. Because BDNF is critical for neuronal function, these results suggest that age- or nutrition-associated declines in NAD levels as well as deficits in cohesin function associated with disease modulate BDNF expression and could contribute to cognitive impairment.

Indexed as

Transcription, GeneticAnimalsBrain-Derived Neurotrophic FactorCCCTC-Binding FactorCell Cycle ProteinsCells, CulturedChromosomal Proteins, Non-HistoneCohesinsDNA MethylationGene Expression RegulationMiceNADNeuronsPromoter Regions, GeneticRepressor ProteinsBrain-Derived Neurotrophic FactorCCCTC-Binding FactorCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsCtcf protein, mouseNADRepressor Proteins

Identifiers

PMID21106760
PMCPMC3003122
OpenAlexW1975163591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.